Copenhagen, 4th June 2024

Sharing our commitment to improving patient lives, our work with Merck will focus on patient-centricity to deliver an intuitive, engaging product that supports users and caregivers throughout their treatment journey. This means speaking with patients to truly understand their unmet needs and how the solution can best address these, as well as hearing from caregivers and healthcare professionals about how to best empower and support those living with GHD.

Thank you to the whole team at Merck and Dawn Health for a collaboration that is already off to a strong start, with workshops and inspiring discussions happening! We are thrilled to be embarking on this journey together and to be working with the driven team at Merck to improve the lives of people living with GHD.

Sharing our commitment to improving patient lives, our work with Merck will focus on patient-centricity to deliver an intuitive, engaging product that supports users and caregivers throughout their treatment journey. This means speaking with patients to truly understand their unmet needs and how the solution can best address these, as well as hearing from caregivers and healthcare professionals about how to best empower and support those living with GHD.

Thank you to the whole team at Merck and Dawn Health for a collaboration that is already off to a strong start, with workshops and inspiring discussions happening! We are thrilled to be embarking on this journey together and to be working with the driven team at Merck to improve the lives of people living with GHD.

Dawn Health is a global leader in digital health, specializing in the development of software as medical device (SaMD) and digital therapeutics (DTx). Partnering with pharmaceutical companies, Dawn Health accelerates the launch of digital solutions to change the lives of people with chronic conditions.